Who invested in TFF Pharmaceuticals?
TFF Pharmaceuticals's investors include National Institute of Allergy and Infectious Diseases and LIQUID VENTURES.
United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$19Mraised across 2 rounds since 2018, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From the SEC filings it signed: 3 on the team.
On the board, as filediAaron S. FletcherHarlan S. WeismanMalcolm S. FairbairnRandy S. ThurmanRobert S. MillsStephen S. Rocamboli
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
TFF Pharmaceuticals's investors include National Institute of Allergy and Infectious Diseases and LIQUID VENTURES.
TFF Pharmaceuticals has raised $19M across 2 rounds since 2018.
TFF Pharmaceuticals's most recent round was an Undisclosed round of $4.8M in Apr 2024.
TFF Pharmaceuticals's largest round on record is $14M (Series A), in Apr 2018.
TFF Pharmaceuticals's first round on record, in Apr 2018, was backed by LIQUID VENTURES.
TFF Pharmaceuticals's latest named round is an Undisclosed round, in Apr 2024.
TFF Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.